SARS-CoV-2 Does Not Infect hMSCs
A new article in STEM CELLS Translational Medicine establishes that human mesenchymal stem cells are not permissive to SARS‐CoV‐2 infection.
https://t.co/8rGonOA2qR
Transplantation of engineered cells is promising for many diseases but oncology has a definite focus as this CD19 clinical trial shows. It's been exciting following progress of CAR T cell therapies recently. #OSUBioE511
https://t.co/fV5Zm4B2uY
Host immune response often impacts the success of #biomaterials. This hydrogel enhanced the survival of #stemcells after transplantation in brain injury with immuno-suppressive Fas ligand. #OSUBioE511 https://t.co/y8PDEwy8Mk
Great article demonstrating the advantage of co-engineering cartilage-bone tissues for a better personalized joint replacement
#OSUBioE511 https://t.co/AZvnZXbt83
The anisotropic microstructure of bone makes it challenging to reproduce outside of the body. Ozasa et. al. have recreated it using an in vitro collagen #TissueEngineering model. #OSUBioE511 https://t.co/tKOivlTPuV